![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Artificial Intelligence for Cancer Detection | iCAD
Transforming cancer detection with artificial intelligence. Explore iCAD's innovative solutions, revolutionizing early diagnosis for improved patient outcomes.
Our Health AI Medical Company Overview | iCAD
The iCAD mission is to create a world where cancer can’t hide, using innovative artificial intelligence solutions. Learn about our health AI medical company.
ProFound AI Breast Cancer Health Suite - iCAD
Explore iCAD's ProFound AI solutions – find breast cancer earlier, with unmatched accuracy, 2x clinical performance, and personalized density and risk assessment.
ECR 2025 - iCAD
With iCAD, reduce diagnostic uncertainty and ensure she gets the right care at the right time, giving her confidence and peace of mind. Learn how iCAD’s AI solutions can elevate your …
NCBC 2025 - iCAD
Introducing iCAD’s AI Platform ProFound Breast Health Suite. Powered by the latest innovations in artificial intelligence (AI), the ProFound Suite offers clinically proven, 360-degree solutions …
News and Events for AI Powered Cancer Detection - iCAD
Nov 26, 2024 · Explore iCAD's webinars, press releases, and media coverage. All focused on how ProFound AI is helping radiologists and patients through early breast cancer detection.
Investors: iCAD Inc Stock Price, Forecast, and Resources | iCAD
Nov 13, 2024 · iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can’t hide, using AI-powered solutions. Explore iCAD stock price and more.
iCAD Pre-Announces Estimated Q4 2024 Revenue | iCAD
iCAD’s consolidated financial statements for the twelve months ended December 31, 2024, are not yet available, and full audited results for the fourth quarter and year ended December 31, …
The Science of Using AI to Detect Breast Cancer - iCAD
Radiologists using iCAD’s best-in-class AI-powered solutions are achieving remarkable outcomes. Learn about the science behind the ProFound solutions to detect breast cancer.
iCAD to Report Third Quarter 2024 Financial Results on November …
Nov 5, 2024 · (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the third quarter ended …